Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Coats disease retina:

Current management of Coats disease. Sigler EJ et al. Surv Ophthalmol. (2014)

Pearls and pitfalls in diagnosis and management of coats disease. Grosso A et al. Retina. (2015)

Coats disease in a 3-week-old boy. Lim Fat CP et al. J AAPOS. (2014)

Search results

Items: 1 to 20 of 564

1.

Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.

Mukherjee D, Lad EM, Vann RR, Jaffe SJ, Clemons TE, Friedlander M, Chew EY, Jaffe GJ, Farsiu S; MacTel Study Group.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO291-BIO299. doi: 10.1167/iovs.17-21834.

PMID:
28973315
2.

RETINAL DETACHMENT SURGERY IN A PEDIATRIC POPULATION: Visual and Anatomic Outcomes.

Read SP, Aziz HA, Kuriyan A, Kothari N, Davis JL, Smiddy WE, Flynn HW Jr, Murray TG, Berrocal A.

Retina. 2017 Aug 28. doi: 10.1097/IAE.0000000000001725. [Epub ahead of print]

PMID:
28858062
3.

Conditional Müller Cell Ablation Leads to Retinal Iron Accumulation.

Baumann B, Sterling J, Song Y, Song D, Fruttiger M, Gillies M, Shen W, Dunaief JL.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4223-4234. doi: 10.1167/iovs.17-21743.

4.

Cyclophotocoagulation-induced sympathetic ophthalmia in a Coats' disease patient supported by histopathology and immunohistochemistry.

Bawankar P, Das D, Tayab S, Kuri GC, Medhi J, Barman M, Soibam R, Bhattacharjee H, Deka P, Misra DK, Dhar S.

Indian J Ophthalmol. 2017 Aug;65(8):744-746. doi: 10.4103/ijo.IJO_228_17.

5.

Optical Coherence Tomography Angiography in Children with Leber-Coats Disease.

Fortunato M, Turtoro A, Cennamo G.

Ophthalmic Res. 2017;58(3):185-187. doi: 10.1159/000478783. Epub 2017 Aug 12.

PMID:
28803250
6.

Coats' disease with retinochoroidal anastomosis.

Rishi P, Rishi E, Bhojwani D.

Oman J Ophthalmol. 2017 May-Aug;10(2):112-113. doi: 10.4103/ojo.OJO_196_2014.

7.

OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.

Runkle AP, Kaiser PK, Srivastava SK, Schachat AP, Reese JL, Ehlers JP.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3683-3689. doi: 10.1167/iovs.16-20976.

8.

The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.

Li S, Deng G, Liu J, Ma Y, Lu H.

BMC Ophthalmol. 2017 May 22;17(1):76. doi: 10.1186/s12886-017-0469-4.

9.

Unveiling idiopathic macular telangiectasia: clinical applications of optical coherence tomography angiography.

Gonzalez MA, Shechtman D, Haynie JM, Semes L.

Eur J Ophthalmol. 2017 Jun 26;27(4):e129-e133. doi: 10.5301/ejo.5000984.

PMID:
28525681
10.

VASCULAR DISTORTION AND DRAGGING RELATED TO APPARENT TISSUE CONTRACTION IN MACULAR TELANGIECTASIS TYPE 2.

Spaide RF, Marco RD, Yannuzzi LA.

Retina. 2017 May 10. doi: 10.1097/IAE.0000000000001694. [Epub ahead of print]

PMID:
28492432
11.

Fluorescein Angiography Versus Optical Coherence Tomography Angiography in Macular Telangiectasia Type I Treated With Bevacizumab Therapy.

Yannuzzi NA, Gregori NZ, Roisman L, Gupta N, Goldhagen BE, Goldhardt R.

Ophthalmic Surg Lasers Imaging Retina. 2017 Mar 1;48(3):263-266. doi: 10.3928/23258160-20170301-12.

PMID:
28297041
12.

Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Scerri TS, Quaglieri A, Cai C, Zernant J, Matsunami N, Baird L, Scheppke L, Bonelli R, Yannuzzi LA, Friedlander M; MacTel Project Consortium, Egan CA, Fruttiger M, Leppert M, Allikmets R, Bahlo M.

Nat Genet. 2017 Apr;49(4):559-567. doi: 10.1038/ng.3799. Epub 2017 Feb 27.

PMID:
28250457
13.

Serum hypercoagulability states in Coats' disease.

Ghassemi F, Shields CL, Mohebbi M, Nili Ahmadabadi M, Morsali F, Sabour S.

Clin Ophthalmol. 2017 Feb 8;11:305-310. doi: 10.2147/OPTH.S121375. eCollection 2017.

14.

A Case of Coats Disease and Concurrent Anisometropic Amblyopia.

Lambert NG, Hoffman RO, Hartnett ME.

Am J Ophthalmol Case Rep. 2016 Dec;4:21-23. doi: 10.1016/j.ajoc.2016.07.004. Epub 2016 Jul 26.

PMID:
28090595
15.

SUBFOVEAL NODULE IN COATS' DISEASE: Toward an Updated Classification Predicting Visual Prognosis.

Daruich AL, Moulin AP, Tran HV, Matet A, Munier FL.

Retina. 2017 Aug;37(8):1591-1598. doi: 10.1097/IAE.0000000000001399.

16.

LONG-TERM ANATOMICAL AND FUNCTIONAL OUTCOMES FOLLOWING VITRECTOMY FOR ADVANCED COATS DISEASE.

Karacorlu M, Hocaoglu M, Sayman Muslubas I, Arf S.

Retina. 2017 Sep;37(9):1757-1764. doi: 10.1097/IAE.0000000000001415.

PMID:
27984550
17.

Fluorescein angiography of subretinal neovascular membrane in parafoveal telangiectasia type II demonstrating retino-retinal, retino-subretinal anastomosis.

Megur B, Megur D, Reddy S.

Indian J Ophthalmol. 2016 Nov;64(11):840-842. doi: 10.4103/0301-4738.195600. No abstract available.

18.

Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report).

Pencak M, Krasny J, Veith M, Vokrojova M.

BMC Ophthalmol. 2016 Nov 11;16(1):200.

19.

LONG-TERM RESULTS OF TOTAL RETINECTOMY IN CASES WITH ADVANCED PROLIFERATIVE VITREORETINOPATHY.

Karacorlu M, Sayman Muslubas I, Hocaoglu M, Arf S, Ersoz MG.

Retina. 2017 Aug;37(8):1529-1534. doi: 10.1097/IAE.0000000000001390.

PMID:
27828913
20.

Diagnostic and Therapeutic Challenges.

Corvi F, Lattanzio R, Miserocchi E, Querques L, Bandello F, Querques G, Croft DE, Wykoff CC.

Retina. 2016 Nov;36(11):2239-2245. No abstract available.

PMID:
27322945

Supplemental Content

Loading ...
Support Center